Access cutting-edge respiratory syncytial virus treatment through this clinical trial at a research site in Doral. Study-provided care at no cost to qualified participants.
Access respiratory syncytial virus specialists in Doral at no cost
This study follows strict safety protocols and ethical guidelines
All study-related respiratory syncytial virus treatment provided free
The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 consecutive RSV seasons (approximately 60 months) of a single dose of RSVPreF3 OA vaccine, * To give the opportunity to participants who received only placebo in the RSVOA=ADJ- 006 study, to receive a dose of the RSVPreF3 OA vaccine and collect additional safety information.
Sponsor: GlaxoSmithKline
Check if you qualify for this respiratory syncytial virus clinical trial in Doral, FL
If you're searching for respiratory syncytial virus treatment options in Doral, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Doral research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory syncytial virus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.